El Grup de Fisiopatologia de les Malalties Relacionades amb Lípids de l’Institut de Recerca del Hospital de la Santa Creu i Sant Pau, és un equip interdisciplinari i de recerca traslacional que treballa en el camp de les malalties cardiovasculars relacionades amb alteracions metabòliques como poden ser les dislipèmies, la diabetis mellitus, l’obesitat, les demències, o la hiperhomocisteinèmia, entre d’altres. La finalitat dels diferents estudis i línies d’investigació del grup es trobar noves teràpies dirigides i/o biomarcadors per tal de disminuir el risc cardiovascular i la malaltia d’Alzheimer en pacients amb aquestes alteracions metabòliques, així com millorar el diagnòstic i control dels pacients
El Grup de Fisiopatologia de les Malalties Relacionades amb Lípids de l’Institut de Recerca del Hospital de la Santa Creu i Sant Pau, és un equip interdisciplinari i de recerca traslacional que treballa en el camp de les malalties cardiovasculars relacionades amb alteracions metabòliques como poden ser les dislipèmies, la diabetis mellitus, l’obesitat, les demències, o la hiperhomocisteinèmia, entre d’altres. La finalitat dels diferents estudis i línies d’investigació del grup es trobar noves teràpies dirigides i/o biomarcadors per tal de disminuir el risc cardiovascular i la malaltia d’Alzheimer en pacients amb aquestes alteracions metabòliques, així com millorar el diagnòstic i control dels pacients
ESCOLA GIL, JOAN CARLES IR
jescola@santpau.cat
Blanco Vaca, Francisco FGS
Borras Querol, Carla IR
Canyelles Vich, Marina FGS
Griñan Gonzalez, Raquel IR
Guiñon Muñoz, Leonor FGS
Illana Camara, Francisco Jose FGS
Martinez Figueroa, Susana FGS
Roig Martinez, Rosa FGS
Rotllan Vila, Noemi IR
Santos Palacios, David CIBERDEM
Sole i Galvez, Arnau CIBERDEM
Tondo Colomer, Mireia FGS
Urgell Rull, Eulalia FGS
Velasco Reniu, Lorena IR
Zapico Muñiz, Edgar FGS
(JIF 2022)
-Asla Q, Sarda H, Segui N, de Pinillos GM, Mazarico I, Capel I, Rives J, Suarez J, avila V, Torres MM, Saigi I, Palacios N, Urgell E, Webb SM, Fernandez M, Oriola J, Mora M, Tondo M, Aulinas A. Clinical and outcome comparison of genetically positive vs. negative patients in a large cohort of suspected familial hypocalciuric hypercalcemia. ENDOCRINE. 2023. DOI:10.1007/s12020-023-03560-y. PMID:38214877. IF:3,700 (Q3/6D). Document type: Article.
-Canyelles M, Blanco F, Pérez A, Escolà JC. Comment on Huh et al. Remnant Cholesterol Is an Independent Predictor of Type 2 Diabetes: A Nationwide Population-Based Cohort Study. Diabetes Care 2023;46:305-312. DIABETES CARE. 2023; 46(10):e203. DOI:10.2337/dc23-0774. PMID:37729500. IF:16,200 (Q1/1D). Document type: Letter.
-Canyelles M, Borràs C, Rotllan N, Tondo M, Escolà JC, Blanco F. Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(3):1940. DOI:10.3390/ijms24031940. PMID:36768264. IF:5,600 (Q1/3D). Document type: Review.
-de las Hazas MCL, del Saz A, Cedó L, Crespo MC, Tomé J, Chapado LA, Macià A, Visioli F, Escola JC, Dávalos A. Hydroxytyrosol Induces Dyslipidemia in an ApoB100 Humanized Mouse Model. MOLECULAR NUTRITION & FOOD RESEARCH. 2023; 68(1). DOI:10.1002/mnfr.202300508. PMID:37933702. IF:5,200 (Q1/3D). Document type: Article.
-Ferrer R, Mansilla A, Tondo M, Blanco F. Remnant cholesterol: new outcomes highlight its potential as a clinically useful cardiovascular risk factor. Journal Of Laboratory And Precision Medicine. 2023; 8:A5. DOI:10.21037/jlpm-22-70. Document type: Note.
-Frutos MFD, Pardo V, Torrecilla M, Rada P, Perez A, Martin Y, de la Pena G, Gomez A, Toledano A, Gomez D, Casarejos MJ, Solis JM, Rotllan N, Pastor O, Ledesma MD, Valverde AM, Busto R, Ramirez CM. “MiR-7 controls cholesterol biosynthesis through posttranscriptional regulation of DHCR24 expression”. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms. 2023; 1866(2):194938. DOI:10.1016/j.bbagrm.2023.194938. PMID:37086967. IF:4,700 (Q1/2D). Document type: Article.
-García A, Muñoz LG, Pallaruelo MC, Usero AM, Eduardo BC, Ramos JL, Canyelles M, Brú CM, Cámara F. Characterization of add-on testing before and after automation at a core laboratory. Heliyon. 2023; 9(11):e22096. DOI:10.1016/j.heliyon.2023.e22096. PMID:38034602. IF:4,000 (Q2/4D). Document type: Article.
-Guiñón L, Illana FJ, Cuevas B, Canyelles M, Martínez C, García Á. Periodic verification of results’ comparability between several analyzers: Experience in the application of the EP31-A-IR guideline. CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2023; 62(3). DOI:10.1515/cclm-2023-0994. PMID:37819627. IF:6,800 (Q1/2D). Document type: Article.
-Hueso M, Rotllan N, Escolà JC, Vellido A. Systems biology and data-driven machine learning-based models in personalized cardiovascular medicine. Frontiers in Cardiovascular Medicine. 2023; 10:1320110. DOI:10.3389/fcvm.2023.1320110. PMID:37965080. IF:3,600 (Q2/5D). Document type: Editorial Material.
-Lee M, Canyelles M, Tondo M, Rotllan N, Kovanen PT, Llorente V, Escola JC. Obesity-induced changes in cancer cells and their microenvironment: Mechanisms and therapeutic perspectives to manage dysregulated lipid metabolism. SEMINARS IN CANCER BIOLOGY. 2023; 93. DOI:10.1016/j.semcancer.2023.05.002. PMID:37156344. IF:14,500 (Q1/1D). Document type: Article.
-Mansilla A, Canyelles M, Ferrer R, Arranz J, Rodriguez I, Zhu N, Rubio S, El Bounasri S, Sanchez O, Torres S, Fortea J, Lleo A, Alcolea D, Tondo M. Effects of storage conditions on the stability of blood-based markers for the diagnosis of Alzheimer’s disease. CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2023; 61(9). DOI:10.1515/cclm-2023-0245. PMID:37083158. IF:6,800 (Q1/2D). Document type: Article.
-Martinez MC, Cortés M, Moreno A, Han L, Ninfali C, Domínguez V, Andrés MJ, Farràs M, Esteve A, Enrich C, Diaz FJ, Pintado B, Escolà JC, de Frutos PG, Andrés V, Melgar P, Postigo A. Atherosclerotic plaque development in mice is enhanced by myeloid ZEB1 downregulation. Nature Communications. 2023; 14(1):8316. DOI:10.1038/s41467-023-43896-7. PMID:38097578. IF:16,600 (Q1/1D). Document type: Article.
-Munoz JP, Sanchez P, Diarte E, Zorzano A, Blanco F, Julve J. FTY720-P, a Biased S1PR Ligand, Increases Mitochondrial Function through STAT3 Activation in Cardiac Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(8):7374. DOI:10.3390/ijms24087374. PMID:37108539. IF:5,600 (Q1/3D). Document type: Article.
-Nan MN, Garcia A, Mora J, Trilla C, Antonijuan A, Orantes V, Cruz M, Blanco F, Llurba E. Impact of Angiogenic and Cardiovascular Biomarkers for Prediction of Placental Dysfunction in the First Trimester of Pregnancy. Biomedicines. 2023; 11(5):1327. DOI:10.3390/biomedicines11051327. PMID:37238997. IF:4,700 (Q1/3D). Document type: Article.
-Puig N, Rives J, Estruch M, Aguilera A, Rotllan N, Camacho M, Colomé N, Canals F, Sánchez JL, Benitez S. Presence of Ceramidase Activity in Electronegative LDL. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(1):165. DOI:10.3390/ijms24010165. PMID:36613609. IF:5,600 (Q1/3D). Document type: Article.
-Puig N, Solé A, Aguilera A, Griñán R, Rotllan N, Camps P, Benitez S. Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(18):14325. DOI:10.3390/ijms241814325. PMID:37762627. IF:5,600 (Q1/3D). Document type: Review.
-Revilla G, Al Qtaish N, Caruana P, Sainz M, Lopez T, Rodriguez F, Paez V, Li CD, Vallverdú NF, Edwards M, Moral A, Pérez JI, Escolà JC, Pedraz JL, Gallego I, Corcoy R, Céspedes MV, Puras G, Mato E. Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior. Biomolecules. 2023; 13(11):1647. DOI:10.3390/biom13111647. PMID:38002329. IF:5,500 (Q1/3D). Document type: Article.
-Revilla G, Ruiz L, Vallverdu NF, Santamaria P, Moral A, Perez JI, Li CD, Fuste V, Lerma E, Corcoy R, Pitoia F, Escola JC, Mato E. Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(13):11153. DOI:10.3390/ijms241311153. PMID:37446330. IF:5,600 (Q1/3D). Document type: Article.
-Rossi G, Belmonte T, Rivas A, Benitez S, Rotllan N, Crespo J, Llorente V, Sanchez JL, de Gonzalo D. Circulating lipoprotein-carried miRNome analysis reveals novel VLDL-enriched microRNAs that strongly correlate with the HDL-microRNA profile. BIOMEDICINE & PHARMACOTHERAPY. 2023; 162:114623. DOI:10.1016/j.biopha.2023.114623. PMID:37023624. IF:7,500 (Q1/1D). Document type: Article.
-Roth L, Dogan S, Tuna BG, Aranyi T, Benitez S, Borrell M, Bozaykut P, De Meyer GRY, Duca L, Durmus N, Fonseca D, Fraenkel E, Gillery P, Giudici A, Jaisson S, Johansson M, Julve J, Lucas AK, Martinet W, Maurice P, McDonnell BJ, Ozbek EN, Pucci G, Pugh C, Rochfort KD, Roks A, Rotllan N, Shadiow J, Sohrabi Y, Spronck B, Szeri F, Terentes D, Aydin ET, Tura O, Ucar E, Yetik G. Pharmacological modulation of vascular ageing: A review from VascAgeNet. AGEING RESEARCH REVIEWS. 2023; 92:102122. DOI:10.1016/j.arr.2023.102122. PMID:37956927. IF:13,100 (Q1/1D). Document type: Review.
-Samouillan V, Garcia E, Benitez A, Lhoest MTLC, Dandurand J, Dato VA, Guerra JM, Escola JC, Chiabrando G, Enrich C, Llorente V. Inhibitory Effects of LRP1-Based Immunotherapy on Cardiac Extracellular Matrix Biophysical Alterations Induced by Hypercholesterolemia. JOURNAL OF MEDICINAL CHEMISTRY. 2023; 66(9). DOI:10.1021/acs.jmedchem.2c02103. PMID:37116069. IF:7,300 (Q1/1D). Document type: Article.
-Soler MC, Romero MD, Todorcevic M, Delgado K, Calatayud C, Benitez A, Lhoest MTL, Mera P, Zagmutt S, Bastias M, Ibeas K, Casals N, Escola JC, Llorente V, Consiglio A, Serra D, Herrero L. Implantation of CPT1AM-expressing adipocytes reduces obesity and glucose intolerance in mice. METABOLIC ENGINEERING. 2023; 77. DOI:10.1016/j.ymben.2023.04.010. PMID:37088334. IF:8,400 (Q1/1D). Document type: Article.
-Sprankel L, Vizarraga D, Martín J, Manger S, Meier J, Marcos M, Julve J, Rotllan N, Scheffer MP, Escolà JC, Langer JD, Piñol J, Fita I, Frangakis AS. Essential protein P116 extracts cholesterol and other indispensable lipids for Mycoplasmas. NATURE STRUCTURAL & MOLECULAR BIOLOGY. 2023; 30(3). DOI:10.1038/s41594-023-00922-y. PMID:36782049. IF:16,800 (Q1/1D). Document type: Article.
-Torres JK, Niño J, Martinez P, Diarte EMG, Méndez KA, del Olmo TV, Rotllan N, Julián MT, Alonso N, Mauricio D, Camacho M, Muñoz JP, Rossell J, Julve J. Nicotinamide Prevents Diabetic Brain Inflammation via NAD+-Dependent Deacetylation Mechanisms. Nutrients. 2023; 15(14):3083. DOI:10.3390/nu15143083. PMID:37513501. IF:5,900 (Q1/2D). Document type: Article.
-Villanueva T, Cedo L, Madeira A, Ceperuelo V, Rodriguez MM, Nunez C, Maymo E, Repolles M, Badia J, Keiran N, Mirasierra M, Pimenta C, Sabadell J, Bosch R, Caubet L, Escola JC, Fernandez JM, Vilarrasa N, Ventura F, Vallejo M, Vendrell J, Fernandez S. SUCNR1 signaling in adipocytes controls energy metabolism by modulating circadian clock and leptin expression. Cell Metabolism. 2023; 35(4):601-619.e10. DOI:10.1016/j.cmet.2023.03.004. PMID:36977414. IF:29,000 (Q1/1D). Document type: Article.
(JIF 2022)